NIH Halts Controversial Industry-Funded Study of Alcohol’s Health Benefits

Public health advocates had argued that the study was hopelessly compromised.

Dr. Francis S. Collins, Director of the National Institutes of HealthTom Williams/ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Update 6/15/18: The National Institutes of Health announced on Friday that it is canceling the controversial study.

The National Institutes of Health (NIH) has put the brakes on a controversial study that was designed to investigate whether alcohol may have cardiovascular benefits for some people. The study was funded with more than $60 million in contributions from alcohol companies. The New York Times reported in March that officials at the National Institute on Alcohol Abuse and Alcoholism, an arm of the NIH, had solicited those industry donations in violation of NIH policies.

NIH Director Francis Collins told members of a Senate subcommittee on Thursday of the research agency’s decision.

In the wake of the Times story, public health advocates had called on NIH to put an end to the study, arguing that it was hopelessly compromised by industry involvement. They said the study was clearly designed with a predetermined outcome to favor the industry’s agenda, and that it might put participants at risk. People in the 7,000-member study would be randomly assigned to consume one drink daily for six years, which is enough to slightly raise the risk of breast and other cancers.

Collins said Thursday that the NIH had ordered researchers last week to stop enrolling new participants and to halt any work on the study until the agency completed a thorough review of its origins and design. “There were sufficient concerns about that study that I would like to tell you that, one week ago, we suspended enrollment in that study on the moderate effects of alcohol on cardiovascular health while we continue the investigation and make a decision about whether the study is, in fact, still worth pursuing,” Collins said. “For NIH, our reputation is so critical, and if we are putting ourselves in a circumstance where that could be called into question, I felt that we had to look at that very seriously and come up with another strategy.”

The NIH task force looking into the study is expected to produce a report in mid-June.

LESS DREADING, MORE DOING

This is the rubber-meets-road moment: the early days in our first fundraising drive since we took a big swing and merged with CIR to bring fearless investigative reporting to the internet, radio, video, and everywhere else that people need an antidote to lies and propaganda.

Donations have started slow, and we hope that explaining, level-headedly, why your support really is everything for our reporting will make a difference. Learn more in “Less Dreading, More Doing,” or in this 2:28 video about our merger (that literally just won an award), and please pitch in if you can right now.

payment methods

LESS DREADING, MORE DOING

This is the rubber-meets-road moment: the early days in our first fundraising drive since we took a big swing and merged with CIR to bring fearless investigative reporting to the internet, radio, video, and everywhere else that people need an antidote to lies and propaganda.

Donations have started slow, and we hope that explaining, level-headedly, why your support really is everything for our reporting will make a difference. Learn more in “Less Dreading, More Doing,” or in this 2:28 video about our merger (that literally just won an award), and please pitch in if you can right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate